Pulmonary tuberculosis and tuberculous arthritis of knee joint associated with rheumatoid arthritis treated with anti-tumor necrosis factor (TNF)-alpha medication: a case report

被引：0
作者：
Selim Nalbant
Mustafa Özyurt
Murat Yıldırım
Mesih Kuskucu
机构：
[1] Maltepe University Medical School,Department of Internal Medicine
[2] Gulhane Military Medical Academy,Department of Microbiology
[3] Haydarpasa Training Hospital,Department of Internal Medicine
[4] Gulhane Military Medical Academy,Department of Orthopedic Surgery
[5] Haydarpasa Training Hospital,undefined
[6] Gulhane Military Medical Academy,undefined
[7] Haydarpasa Training Hospital,undefined
来源：
Rheumatology International | 2012年 / 32卷
关键词：
Rheumatoid arthritis; Anti-TNF agents; Knee joint; Tuberculosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Tuberculosis infection (TB) is one of the most important problems for the rheumatoid arthritis (RA) patients treated with anti-TNF agents. Pulmonary tuberculosis is the most common clinic form of the TB in these patients. However, tuberculosis arthritis is very rare. We present here a 72-year-old Caucasian woman with seropositive RA, treated with etanercept/adalimumab for the last 2 years, who presented with resistant knee pain and joint effusion. We believe that this treatment caused the tuberculosis in this patient, which is the most worried complication. Interestingly, tuberculosis was in the knee joint at this time.
引用
收藏
页码：2863 / 2866
页数：3
相关论文
共 59 条
[1]  
Spector TD(1990)Rheumatoid arthritis Rheum Dis Clin North Am 16 513-214
[2]  
Brassard P(2006)Antirheumatic drugs and the risk of tuberculosis Clin Infect Dis 43 717-1206
[3]  
Kezouh A(2005)Risk, case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden Arthritis Rheum 52 1986-346
[4]  
Suissa S(2004)Trends in tuberculosis–United States, 1998 to 2003 MMWR Morb Mortal Wkly Rep 53 209-685
[5]  
Askling J(2003)Anti-tumour necrosis factor agents, tuberculosis risk: mechanisms of action, clinical management Lancet Infect Dis 3 148-401
[6]  
Fored CM(2003)Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report Arthritis Rheum 48 2122-undefined
[7]  
Brandt L(2010)The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Eur Respir J 36 1185-undefined
[8]  
Gardam MA(2002)Guidelines for the management of rheumatoid arthritis 2002 update Arthritis Rheum 46 328-undefined
[9]  
Keystone EC(2008)Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008 Ann Rheum Dis 67 iii2-undefined
[10]  
Menzies R(2010)Risk of tuberculosis in patients with rheumatoid arthritis in Hong Kong–the role of TNF blockers in an area of high tuberculosis burden Clin Exp Rheumatol 28 679-undefined
123456